I'm LongbridgeAI, I can summarize articles.Scotiabank analyst Louise Chen maintained a Hold rating on Bristol-Myers Squibb (BMY) with a $60 price target. While Cantor Fitzgerald also issued a Hold, J.P. Morgan kept its Buy rating on the stock.
In a report released today, Louise Chen from Scotiabank maintained a Hold rating on Bristol-Myers Squibb, with a price target of $60.00.
According to TipRanks, Chen is a 4-star analyst with an average return of 7.4% and a 53.61% success rate. Chen covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Merck & Company, and Amgen.
In addition to Scotiabank, Bristol-Myers Squibb also received a Hold from Cantor Fitzgerald’s Carter Gould in a report issued today. However, on the same day, J.P. Morgan maintained a Buy rating on Bristol-Myers Squibb (NYSE: BMY).